Latest Articles
FOCL: Robotic focal therapy growth accelerates with HIFU innovation, new indications, and global expansion - TradingView
FOCL: Robotic focal therapy growth accelerates with HIFU innovation, new indications, and global expansion TradingView
Published: June 4, 2026, 7:18 p.m.
AstraZeneca removing breast cancer drug from Australia - Australian Broadcasting Corporation
AstraZeneca removing breast cancer drug from Australia Australian Broadcasting Corporation
Published: June 4, 2026, 8 a.m.
Morven-May MacCallum MSP: No-one in Scotland should have to fight harder to be believed than to get well - Liberal Democrat Voice
Morven-May MacCallum MSP: No-one in Scotland should have to fight harder to be believed than to get well Liberal Democrat Voice
Published: June 4, 2026, 7:52 a.m.
AUDIO: AstraZeneca pulls critical breast cancer drug from shelves - Australian Broadcasting Corporation
AUDIO: AstraZeneca pulls critical breast cancer drug from shelves Australian Broadcasting Corporation
Published: June 3, 2026, 9:59 p.m.
Elderly Tenterfield couple stabbed, alleged intruder shot during home invasion - Australian Broadcasting Corporation
Elderly Tenterfield couple stabbed, alleged intruder shot during home invasion Australian Broadcasting Corporation
Published: June 3, 2026, 9:21 p.m.
Life-saving breast cancer and endometriosis drug to be discontinued - Australian Broadcasting Corporation
Life-saving breast cancer and endometriosis drug to be discontinued Australian Broadcasting Corporation
Published: June 3, 2026, 6:49 p.m.
Lifesaving breast cancer and endometriosis drug to be pulled from shelves - Australian Broadcasting Corporation
Lifesaving breast cancer and endometriosis drug to be pulled from shelves Australian Broadcasting Corporation
Published: June 3, 2026, 6:49 p.m.
Life-saving breast cancer and endometriosis drug to be pulled from shelves - Australian Broadcasting Corporation
Life-saving breast cancer and endometriosis drug to be pulled from shelves Australian Broadcasting Corporation
Published: June 3, 2026, 6:49 p.m.
TCRI Celebrates Research Appreciation Day 2026 - Texas Children’s
TCRI Celebrates Research Appreciation Day 2026 Texas Children’s
Published: June 3, 2026, 6:04 p.m.
Addition of Pembrolizumab to Chemotherapy Continues to Demonstrate Overall Survival Benefit in Advanced or Recurrent Endometrial Cancer - The ASCO Post
Addition of Pembrolizumab to Chemotherapy Continues to Demonstrate Overall Survival Benefit in Advanced or Recurrent Endometrial Cancer The ASCO Post
Published: June 3, 2026, 2:49 p.m.
Link copied to clipboard!